Question:
When do the new level II codes Q5108 and Q5110 take effect?
Answer:
The effective date for code Q5108–injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg—is July 12, 2018. For Q5110–injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram—the effective date is October 1, 2018. The implementation date for both codes is October 1, 2018. This information can be found at https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R4134CP.pdf.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2025 MedLearn Publishing. Powered by MedLearn Media.
Notifications